ArticleJournal of neuroinflammation2026
Glymphatic dysfunction contributes to thalamic iron retention and secondary thalamic injury after stroke: evidence from primates and rodents.
Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundSecondary neurodegeneration, characterized by neuronal loss and neuroinflammation, in the remote thalamus is associated with post-stroke cognitive impairment (PSCI). This study aimed to elucidate common pathological mechanism of the secondary neurodegeneration in both primates and rodents.
methodsThalamic amyloid-β (Aβ), iron deposition and glymphatic dysfunction was assessed across primate and rodent stroke models in different time points, using histopathological, and magnetic resonance imaging methods. Proteomic analysis was performed to explore the molecular mechanisms underlying the secondary thalamic damage. Neuronal loss and neuroinflammation were assessed through histopathological methods. Using aquaporin-4 (AQP4) inhibitor, we investigated whether glymphatic inhibition aggravated thalamic iron deposition and PSCI.
resultsAβ accumulated in the remote thalamus of mice but was absent in cynomolgus monkeys by imaging and histology, and Aβ40/42 remained unchanged in plasma and cerebrospinal fluid in monkeys following stroke. Instead, quantitative susceptibility mapping MRI and Prussian blue staining uncovered progressive iron deposition in the remote thalamus shared by both species, alongside ferroptosis activation. Glymphatic imaging and AQP4 analyses showed impaired glymphatic clearance and loss of AQP4 perivascular polarization, which worsened along with time. Both stroke monkeys and mice exhibited neuronal injury and increased neuroinflammation in the remote thalamus, with cognitive impairment. Glymphatic inhibition with TGN-020 exacerbated iron deposition and ferroptosis, leading to more severe neuronal loss and microglial proliferation, ultimately aggravating PSCI. In addition, CD31 and ZO-1 co-immunostaining demonstrated blood-brain-barrier damage, with reduced ZO-1 colocalization with CD31.
conclusionsIron deposition and ferroptosis-related changes were consistently observed in the remote thalamus across both rodent and primate models, whereas Aβ accumulation appeared to be species-dependent. Glymphatic dysfunction and blood-brain barrier damage in the remote thalamus may jointly facilitates iron accumulation and ferroptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.